Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018.

GAP III accident containment breach incident poliovirus risk assessment

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
22 Jun 2020
Historique:
received: 09 06 2020
revised: 19 06 2020
accepted: 19 06 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 26 6 2020
Statut: epublish

Résumé

The safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have already been documented. Here, we report the management of an incident that occurred on 30 November 2018 in a French vaccine manufacturing plant. Five adequately vaccinated operators were exposed to a Sabin poliovirus type 3 (PV3) spill. A microbiological risk assessment was conducted and the operators were monitored for PV shedding. On day 5 after exposure, Sabin PV3 was detected only in the stool sample of the most exposed worker. Shedding of Sabin PV3 (as detected by viral culture) was restricted to a very short period (less than 15 days). Monitoring of this incident was an opportunity to assess the relevance of our national response plan. We concluded that the measures undertaken and reported here were appropriate and proportional.

Identifiants

pubmed: 32580378
pii: vaccines8020331
doi: 10.3390/vaccines8020331
pmc: PMC7350213
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Euro Surveill. 2016;21(11):30169
pubmed: 27020766
J Virol Methods. 2014 Mar;197:25-8
pubmed: 24321704
J Infect Dis. 1997 Sep;176(3):617-24
pubmed: 9291306
J Infect Dis. 2011 Apr 1;203(7):898-909
pubmed: 21402542
Euro Surveill. 2017 May 25;22(21):
pubmed: 28597830
J Clin Microbiol. 2006 Aug;44(8):2698-704
pubmed: 16891480
Emerg Infect Dis. 2019 Jul;25(7):1363-1369
pubmed: 31082331
Indian J Med Res. 2003 Dec;118:217-23
pubmed: 14870793

Auteurs

Marion Jeannoël (M)

Centre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, France.

Denise Antona (D)

Santé publique France, 94410 Saint Maurice, France.

Clément Lazarus (C)

Public Health Emergency Operations Centre, Division of Surveillance and Health Security, General Directorate for Health, Ministry of Solidarity and Health, 75350 Paris, France.

Bruno Lina (B)

Centre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, France.
Laboratoire Virpath, Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, Inserm U1111, CNRS UMR 5308, ENS de Lyon, UCBL, 69372 Lyon, France.

Isabelle Schuffenecker (I)

Centre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, France.

Classifications MeSH